Mateos, M.-V., Bringhen, S., Richardson, P. G., Lahuerta, J. J., Larocca, A., Oriol, A., Boccadoro, M., García-Sanz, R., Di Raimondo, F., Esseltine, D.-L., van de Velde, H., Desai, A., Londhe, A., San Miguel, J. F. and Palumbo, A. (2014) “Bortezomib cumulative dose, efficacy, and tolerability with three different bortezomib-melphalan-prednisone regimens in previously untreated myeloma patients ineligible for high-dose therapy”, Haematologica. Pavia, Italy, 99(6), pp. 1114-1122. doi: 10.3324/haematol.2013.099341.